ADAR1 Capital Management »

Ikena Oncology shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Ikena Oncology (IKNA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Ikena Oncology

Tip: Access up to 7 years of quarterly data

All positions including Ikena Oncology held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ikena Oncology by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $77k 45k 1.73
2024-06-30 $77k 47k 1.65
2024-03-31 $50k 35k 1.42

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Ikena Oncology

Atlas Venture Life Science Advisors
BVF
Blue Owl Capital Holdings
OrbiMed Advisors
Omega Fund Management
Vanguard Group
Adage Capital Partners GP
BML Capital Management
NEA Management Company
Acuitas Investments
Renaissance Technologies
Jacobs Levy Equity Management
Sofinnova Ventures
BlackRock
Acadian Asset Management

View all funds holding Ikena Oncology